Tianshui Zhongxing Bio-technology Co

Tianshui Zhongxing Bio-technology Co FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Tianshui Zhongxing Bio-technology Co (002772.SZ) as of Oct 15, 2026 is -14.34 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 194.77 % — a change of -107.36% (lower).

FCF Conversion

-14.34 %

YoY

-107.36%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Tianshui Zhongxing Bio-technology Co is 2025 -14.34 % . FCF Conversion Rate (FCF/EBITDA) of Tianshui Zhongxing Bio-technology Co was 2024 194.77 % . It decreases by -107.36% lower compared to the previous year.

The Tianshui Zhongxing Bio-technology Co FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
-375.09 CNY
Jan 1, 2019
-445.11 CNY
Jan 1, 2020
5.07 CNY
Jan 1, 2021
-1,273.74 CNY
Jan 1, 2022
156.51 CNY
Jan 1, 2023
261.63 CNY
Jan 1, 2024
194.77 CNY
Jan 1, 2025
-14.34 CNY
The Tianshui Zhongxing Bio-technology Co FCF Conversion history
YEARFCF ConversionYoY
-14.34 %-107.36%
194.77 %-25.55%
261.63 %+67.16%
156.51 %-112.29%
-1,273.74 %-25,235.60%
5.07 %-101.14%
-445.11 %+18.67%
-375.09 %+81.02%
-207.21 %+33.38%
-155.36 %-847.71%
20.78 %-190.20%
-23.04 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Tianshui Zhongxing Bio-technology Co Stock analysis

What does Tianshui Zhongxing Bio-technology Co do? Tianshui Zhongxing Bio-technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tianshui Zhongxing Bio-technology Co stock

FCF Conversion Rate (FCF/EBITDA) of Tianshui Zhongxing Bio-technology Co is -14.34 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Tianshui Zhongxing Bio-technology Co changed from 194.77 % to -14.34 %, representing a -107.36% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Tianshui Zhongxing Bio-technology Co since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Tianshui Zhongxing Bio-technology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Tianshui Zhongxing Bio-technology Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Tianshui Zhongxing Bio-technology Co